Skip to main content
. 2019 Nov 17;8(11):2006. doi: 10.3390/jcm8112006

Table 1.

Baseline characteristics.

SZR +
(n = 51)
SZR −
(n = 584)
p
Demographic Data and Baseline Clinical Characteristics
Age, years 72.3 ± 14.8 77.5 ± 11.5 0.003
Males, n (%) 21 (41.2) 276 (47.3) 0.4
Stroke subtypes 0.001
IS, n (%) 35 (68.6) 506 (86.6)
ICH, n (%) 16 (31.4) 78 (13.4)
IS subtypes based on TOAST classification 0.08
Large artery atherosclerosis, n (%) 2 (5.7) 58 (11.5)
Cardioembolism, n (%) 9 (25.7) 98 (19.4)
Small-vessel occlusion, n (%) 1 (2.9) 82 (16.2)
Other determined etiology, n (%) 2 (5.7) 9 (1.8)
Undetermined etiology, n (%) 21 (60) 259 (51.2)
IS subtypes based on OCSP classification 0.001
TACI, n (%) 9 (25.7) 36 (7.1)
PACI, n (%) 22 (62.9) 270 (53.4)
POCI, n (%) 1 (2.9) 86 (17)
LACI, n (%) 3 (8.6) 114 (22.5)
ICH localization 0.01
Lobar, n (%) 9 (56.3) 18 (23.1)
Deep, n (%) 7 (43.8) 60 (76.9)
NIHSS score at admission, median (IQR) 10 (4–17) 5 (2–14) 0.01
pre-stroke mRS, median (IQR) 0 (0-2) 0 (0-2) 0.2
Vascular risk factors
Hypertension, n (%) 37 (72.5) 475 (81.3) 0.9
Atrial fibrillation, n (%) 17 (33.3) 195 (33.4) 0.4
Diabetes mellitus, n (%) 11 (21.6) 140 (24.0) 0.7
Hypercholesterolemia, n (%) 13 (25.5) 140 (24.0) 0.8
Smoking, n (%) 9 (17.6) 101 (17.3) 0.9
Laboratory findings
Sodium 0.3
Hyponatremia, n (%) 7 (13.7) 45 (7.7)
Hypernatremia, n (%) 1 (2.0) 8 (1.4)
Potassium 0.4
Hypokalemia, n (%) 5 (9.8) 98 (16.8)
Hyperkalemia, n (%) 4 (7.8) 37 (6.3)
Glucose 0.2
Hypoglycemia, n (%) 0 (0) 0 (0)
Hyperglycemia, n (%) 37 (72.5) 370 (63.4)

SZR +: patients with post-stroke seizures; SZR −: patients without post-stroke seizures; IS = ischemic stroke; ICH: intracranial hemorrhage; TOAST: Trial of ORG 10,172 in Acute Stroke Treatment; OCSP: Oxfordshire Community Stroke Project; TACI: total anterior circulation infarction; PACI: partial anterior circulation infarction; POCI: posterior circulation infarct; LACI: lacunar infarct; NIHSS: National Institute of Health Stroke Scale; mRS = modified Rankin Scale.